BKBelgin Küçükyangöz

Belgin Küçükyangöz

*This is an algorithmically generated author record based on publicly available information.

Belgin Küçükyangöz has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Publication Outcomes of Dermatology Residency Theses in Türkiye and Their Determinants

    by Belgin Küçükyangöz

    Objective: Medical specialty theses are not only an educational requirement but also valuable scientific studies that contribute to the literature when published. This study aimed to determine the publication rates of dermatology theses and the factors influencing this process.Materials and Methods: Dermatology theses registered in the National Thesis Center between 2018 and 2022 were reviewed. These were classified according to title, subject, year, author and supervisor information, institution type, and research method. Publication status was determined by searching PubMed, Google Scholar, Web of Science (WoS), Scopus, and TR Index. For published articles, journal index coverage, impact factor, CiteScore, citation count, publication time, and supervisors’ h-index were recorded.Results: The study included 321 dermatology theses, and 120 of these (37.4%) were converted into publications. Among them, 94 (78.3%) appeared in SCI/SCI-Expanded indexed journals. The median time to publication was 2 years (IQR: 2–3), the median citation count was 2 (IQR: 0–6), CiteScore 4.1 (IQR: 1.8–5.1), and impact factor 2.3 (IQR: 1.6–3.1). No significant relationship was observed between publication status and author gender, advisor title, institution type, thesis topic, research type, or study design. A significant association was found with thesis year (p

  • Open Access

    Evaluation of Sense of Smell in Onychomycosis Patients Receiving Terbinafine Treatment

    by Mualla Polat, Tekden Karapinar, Belgin Küçükyangöz, Yusuf Özgür Bi̇çer, Özge Uzun, Tuna Sezer

    Aim: The most common side effects of terbinafine are gastrointestinal symptoms. Loss of taste and smell side effects are presented in a small number of case reports. We aimed to measure the effect of terbinafine on the sense of smell and the degree of change in the sense of smell in this study. Material and Methods: Odor identification test (OIT), odor threshold test (OTT), and odor discrimination test (ODT) were applied to the patients treated with terbinafine and the control group. It was applied with “Sniffin Sticks” test pens. Smell test was performed on the patient group just before the start of terbinafine treatment and at the end of 3 months of treatment. Results: There was no statistical difference between the patient and control groups in terms of age (p=0.991) and gender (p=0.811). There was no statistical difference when the initial odor tests of the patient group and the control group were compared. The OIT value of the patient group was 10.15±1.43 at the beginning and 10.10±1.15 at the end of the treatment (p=0.743). The OTT values were 6.23±1.08 at the beginning and 6.21±0.85 at the end of the treatment (p=0.811). The ODT values were 9.71±1.44 at the beginning and 9.69±1.34 at the end of the treatment (p=0.767). There was no statistical difference in the results of the tests performed at the beginning and end of the treatment. Conclusion: There was no adverse effect on the sense of smell associated with the use of systemic terbinafine treatment for 3 months.